(Q44867167)

7 December 2017

title

Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas (English)

1 reference

Erb-b2 receptor tyrosine kinase 2

7 December 2017

main subject

1 reference

8

Kyoung-Mee Kim

1 reference

7 December 2017

Eun Yoon Cho

1

1 reference

7 December 2017

Kyeongmee Park

2

1 reference

7 December 2017

Ingu Do

3

1 reference

7 December 2017

Junhun Cho

4

1 reference

7 December 2017

Jiyun Kim

5

1 reference

7 December 2017

Jeeyun Lee

6

1 reference

7 December 2017

Seonwoo Kim

7

1 reference

7 December 2017

Tae Sung Sohn

9

1 reference

7 December 2017

Won Ki Kang

10

1 reference

7 December 2017

Sung Kim

11

1 reference

7 December 2017

publication date

14 December 2012

1 reference

7 December 2017

1 reference

7 December 2017

volume

26

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

677-684

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.205

7 December 2017

exact match

0 references

cites work

Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Correlation of c-erbB-2 protein expression and lymph node status in early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

HER-2/neu amplification is an independent prognostic factor in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

HER-2 amplification is highly homogenous in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

HER2 gene status in primary breast cancers and matched distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Targeted HER2 treatment in advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Comparison of four immunohistochemical tests and FISH for measuring HER2 expression in gastric carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

HER2 testing in gastric cancer: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

7 January 2021

Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

7 January 2021

c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

7 January 2021

Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

7 January 2021

Comparative study on overexpression of HER2/neu and HER3 in gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

7 January 2021

HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.205

7 January 2021

10.1038/MODPATHOL.2012.205

Identifiers

DOI

1 reference

7 December 2017

1 reference